Dario A. Paggiarino, Chief Medical Officer at EyePoint Pharmaceuticals, Inc. (EYPT), sold 300 shares at $25.00 ($8K) on 2024-01-25, disclosed to the SEC on 2024-01-29.
Open-market sale of $8k EYPT by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| EYPT | SELL | 2024-01-10 | $968K | — | Filing → |
| EYPT | SELL | 2023-12-15 | $29K | — | Filing → |
| EYPT | SELL | 2023-12-06 | $674K | — | Filing → |